Aldesleukin Completed Phase 1 Trials for Regional Neuroblastoma / Recurrent Neuroblastoma / Disseminated Neuroblastoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00005576Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma